Literature DB >> 35511492

Increased radiosensitivity and impaired DNA repair in patients with STAT3-LOF and ZNF341 deficiency, potentially contributing to malignant transformations.

Sukru Cekic1, Huzeyfe Huriyet2, Melika Hortoglu2, Nurhan Kasap3, Ahmet Ozen3,4,5, Elif Karakoc-Aydiner3,4,5, Ayse Metin6, Gokhan Ocakoglu7, Candan Demiroz Abakay8, Sehime G Temel9, Sebnem Ozemri Sag9, Safa Baris3,4,5, Tolga Cavas2, Sara Sebnem Kilic1,10.   

Abstract

STAT3 plays an important role in various complex and sometimes contradictory pathways such as proliferation, differentiation, migration, inflammation, and apoptosis. The transcriptional activity of the STAT3 gene is controlled by a transcription factor called ZNF341. There is insufficient data on radiation sensitivity and post-radiation DNA repair in STAT3- loss-of-function (LOF) patients. We aimed to investigate the radiosensitivity in patients with STAT3-LOF and ZNF341 deficiency. Twelve patients with STAT3-LOF and four ZNF341-deficiency patients were recruited from three clinical immunology centers in Turkey and evaluated for radiosensitivity by the Comet assay, comparing to 14 age- and sex-matched healthy controls. The tail length (TL) (μm), percentage of DNA in the tail (TDNA%), and olive tail moment (OTM) (arbitrary units) were evaluated at the same time for baseline (spontaneous), initial (immediately after 2 Gy irradiation), and recovery (2 h after irradiation) periods by using a computerized image-analysis system, estimating DNA damage. Except for a patient with ZNF341 deficiency who developed nasal cell primitive neuroendocrine tumor and papillary thyroid cancer during the follow-up, there was no cancer in both groups. During the recovery period of irradiation, TL, TDNA%, and OTM values of healthy controls decreased rapidly toward the baseline, while these values of patients with STAT3-LOF and ZNF341 deficiency continued to increase, implying impaired DNA repair mechanisms. Increased radiosensitivity and impaired DNA repair were demonstrated in patients diagnosed with STAT3-LOF and ZNF341 deficiency, potentially explaining the susceptibility to malignant transformation.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Comet assay; DNA repair; STAT3-LOF; ZNF-341 deficiency; radiosensitivity

Mesh:

Substances:

Year:  2022        PMID: 35511492      PMCID: PMC9307231          DOI: 10.1093/cei/uxac041

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  36 in total

1.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 2.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

3.  Cancer Tendency in a Patient with ZNF341 Deficiency.

Authors:  Sukru Cekic; Julia Maria Hartberger; Stefanie Frey-Jakobs; Huzeyfe Huriyet; Melika Bektas Hortoglu; Johanna Charlotte Neubauer; Yasin Karali; Candan Demiroz Abakay; Ozlem Saraydaroglu; Tolga Cavas; Bodo Grimbacher; Sara Sebnem Kilic
Journal:  J Clin Immunol       Date:  2020-01-24       Impact factor: 8.317

Review 4.  Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.

Authors:  Attila Kumánovics; Sherrie L Perkins; Heather Gilbert; Melissa H Cessna; Nancy H Augustine; Harry R Hill
Journal:  J Clin Immunol       Date:  2010-09-22       Impact factor: 8.317

5.  Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.

Authors:  Marie-Olivia Chandesris; Isabelle Melki; Angels Natividad; Anne Puel; Claire Fieschi; Ling Yun; Caroline Thumerelle; Eric Oksenhendler; David Boutboul; Caroline Thomas; Cyrille Hoarau; Yvon Lebranchu; Jean-Louis Stephan; Celine Cazorla; Nathalie Aladjidi; Marguerite Micheau; François Tron; André Baruchel; Vincent Barlogis; Gilles Palenzuela; Catherine Mathey; Stéphane Dominique; Gérard Body; Martine Munzer; Fanny Fouyssac; Rolland Jaussaud; Brigitte Bader-Meunier; Nizar Mahlaoui; Stéphane Blanche; Marianne Debré; Muriel Le Bourgeois; Virginie Gandemer; Nathalie Lambert; Virginie Grandin; Stéphanie Ndaga; Corinne Jacques; Chantal Harre; Monique Forveille; Marie-Alexandra Alyanakian; Anne Durandy; Christine Bodemer; Felipe Suarez; Olivier Hermine; Olivier Lortholary; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Medicine (Baltimore)       Date:  2012-07       Impact factor: 1.889

6.  STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Qu Zhang; Chi Zhang; Jia He; Qing Guo; Desheng Hu; Xi Yang; Jinfeng Wang; Yahui Kang; Ruifang She; Zhongming Wang; Defan Li; Guanhong Huang; Zhaoming Ma; Weidong Mao; Xiaoyi Zhou; Chuangying Xiao; Xinchen Sun; Jianxin Ma
Journal:  Tumour Biol       Date:  2014-12-10

Review 7.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

8.  YM155 decreases radiation-induced invasion and reverses epithelial-mesenchymal transition by targeting STAT3 in glioblastoma.

Authors:  Xin Zhang; Xuehai Wang; Ran Xu; Jianxiong Ji; Yangyang Xu; Mingzhi Han; Yuzhen Wei; Bin Huang; Anjing Chen; Qing Zhang; Wenjie Li; Jian Wang; Xingang Li; Chen Qiu
Journal:  J Transl Med       Date:  2018-03-23       Impact factor: 8.440

Review 9.  The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy.

Authors:  Manlio Tolomeo; Antonio Cascio
Journal:  Int J Mol Sci       Date:  2021-01-09       Impact factor: 5.923

10.  A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

Authors:  Vivien Béziat; Juan Li; Jian-Xin Lin; Cindy S Ma; Peng Li; Aziz Bousfiha; Isabelle Pellier; Samaneh Zoghi; Safa Baris; Sevgi Keles; Paul Gray; Ning Du; Yi Wang; Yoann Zerbib; Romain Lévy; Thibaut Leclercq; Frédégonde About; Ai Ing Lim; Geetha Rao; Kathryn Payne; Simon J Pelham; Danielle T Avery; Elissa K Deenick; Bethany Pillay; Janet Chou; Romain Guery; Aziz Belkadi; Antoine Guérin; Mélanie Migaud; Vimel Rattina; Fatima Ailal; Ibtihal Benhsaien; Matthieu Bouaziz; Tanwir Habib; Damien Chaussabel; Nico Marr; Jamel El-Benna; Bodo Grimbacher; Orli Wargon; Jacinta Bustamante; Bertrand Boisson; Ingrid Müller-Fleckenstein; Bernhard Fleckenstein; Marie-Olivia Chandesris; Matthias Titeux; Sylvie Fraitag; Marie-Alexandra Alyanakian; Marianne Leruez-Ville; Capucine Picard; Isabelle Meyts; James P Di Santo; Alain Hovnanian; Ayper Somer; Ahmet Ozen; Nima Rezaei; Talal A Chatila; Laurent Abel; Warren J Leonard; Stuart G Tangye; Anne Puel; Jean-Laurent Casanova
Journal:  Sci Immunol       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.